RxDoctor Payments Data

Jeffrey Schwimmer

Pediatric Gastroenterology · San Diego, CANPI 1932270782

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,539 of the $4,060 with a category attached, or 62.5%. 3 manufacturers reported payments, led by Merck at 43.6% of the total.

$4,060in general payments, 2019–2025

Across 6 payments — averaging $676.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2K
  • Madrigal Pharmaceuticals$2K
  • Novo Nordisk AS$770
$998,944in research payments, 2019–2025

Across 16 payments — averaging $62,434 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$999K

What the payments were for

  • Consulting fees$2,53963%
  • Speaking & faculty fees$1,41035%
  • Travel & lodging$361%
  • Food & beverage$762%

General payments by program year

19
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck2$1,769
Madrigal Pharmaceuticals3$1,522
Novo Nordisk AS1$770

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,060 in reported general payments places this provider in the 80th percentile of 220 pediatric gastroenterology providers in California.

See all pediatric gastroenterology providers in California

Other pediatric gastroenterology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →